Cardiology (Cardinova)
Cardiology is the branch of medicine that focuses on the heart and cardiovascular system, addressing conditions such as high cholesterol, heart disease, and cardiovascular risk management. At Seynapsis Pharma Pvt. Ltd., we provide safe, effective, and affordable cardiology medicines to improve heart health and overall well-being.
Our flagship product, ROSSTAT (Rosuvastatin 20 mg), is designed to manage hyperlipidemia and reduce cardiovascular risks, offering reliable therapy for patients and healthcare professionals.
Committed to scientific innovation, quality, and patient-centric care, Seynapsis Pharma ensures that our cardiology solutions contribute to healthier hearts and better lives.
1. ROSSTAT – Rosuvastatin 20 mg Tablets
Strength - 20 mg Pack
Size - 10 x 10 Tablets (Alu-Alu blister)
Each film-coated tablet contains:
Rosuvastatin Calcium IP equivalent to Rosuvastatin 20 mg
Excipients: q.s.
Colours: Ponceau 4R & Titanium Dioxide IP.
Most potent statin with high LDL-C reduction at lower doses
Raises HDL cholesterol and reduces triglycerides effectively
Reduces risk of myocardial infarction, stroke, and revascularization procedures
Favorable tolerability and safety profile compared to other statins
Once-daily dosing → better patient compliance.
Indication : Hyperlipidemia, prevention of cardiovascular disease
2.Telmisartan & Metoprolol Succinate (ER) Tablets SEYTEL-M 25
Strength - 25 mg Pack
Size - 10 x 10 Tablets (Alu-Alu blister)
Composition
Each film-coated bilayered tablet contains:
Telmisartan IP – 40 mg
Metoprolol Succinate IP (Extended Release) – equivalent to
Metoprolol Tartrate 25 mgExcipients – q.s.
Colour: Ferric Oxide Red USP-NF
Dual blood pressure control: Combines two antihypertensive mechanisms for better BP management.
Reduces heart workload: Metoprolol lowers heart rate and myocardial oxygen demand.
Vascular protection: Telmisartan relaxes blood vessels by blocking angiotensin II.
24-hour BP control: Extended-release metoprolol provides sustained action.
Improves cardiovascular outcomes: Helps reduce risk of complications related to hypertension.
SEYTEL-M 25 is indicated for:
Hypertension (high blood pressure), especially when single-drug therapy is inadequate
Hypertension associated with increased heart rate
Prevention of cardiovascular events (such as heart attack or stroke) in high-risk patients, as advised by a physician
3.Telmisartan Tablets IP 40 mg Rx SEYTEL-40
Strength - 40 mg Pack
Size - 10 x 10 Tablets (Alu-Alu blister)
Telmisartan IP – 40 mg
Excipients – q.s.
- Angiotensin II Receptor Blocker (ARB) for effective blood pressure control
Provides long-lasting 24-hour antihypertensive action
Helps reduce the risk of cardiovascular events
Once-daily dosing for better patient compliance
Hypertension (high blood pressure)
Reduction of risk of:
Stroke
Myocardial infarction (heart attack)
Cardiovascular complications associated with hypertension
4.Telmisartan & Amlodipine Tablets IP SEYTEL-AM
Strength - 40 mg Pack
Size - 10 x 10 Tablets (Alu-Alu blister)
Telmisartan IP – 40 mg
Amlodipine Besilate IP – equivalent to Amlodipine 5 mg
Excipients – q.s.
Colour: Lake of Ponceau 4R (in Amlodipine Besilate layer)
Dual-action antihypertensive therapy combining an ARB (Telmisartan) and a Calcium Channel Blocker (Amlodipine)
Provides effective and sustained 24-hour blood pressure control
Helps achieve better BP control in patients not adequately controlled on monotherapy
Once-daily dosing improves patient compliance
Reduces cardiovascular workload and vascular resistance
Bilayered tablet for optimized drug release
Moisture-sensitive tablet – protected packaging required
Schedule H (Rx) prescription drug – use under medical supervision only
Hypertension (high blood pressure)
Patients requiring combination therapy for optimal blood pressure control
Reduction of risk of cardiovascular complications such as:
Stroke
Myocardial infarction (heart attack)
Other hypertension-related cardiovascular events
5.Telmisartan Tablets IP 20 mg Rx SEYTEL-20
Strength - 20 mg Pack
Size - 10 x 10 Tablets (Alu-Alu blister)
Telmisartan IP – 20 mg
Excipients – q.s.
Angiotensin II Receptor Blocker (ARB) for effective blood pressure control
Suitable for initiation of antihypertensive therapy and dose titration
Provides smooth and sustained 24-hour blood pressure control
Once-daily dosing improves patient compliance
Helps protect heart, blood vessels, and kidneys
Moisture-sensitive tablet – requires protective packaging
Well tolerated when used as prescribed
Schedule H (Rx) drug – to be used only under medical supervision
Treatment of hypertension (high blood pressure)
Initial therapy in patients requiring low-dose ARB
Dose adjustment in elderly patients or those sensitive to antihypertensive therapy
Reduction of risk of hypertension-related complications such as:
Stroke
Myocardial infarction
Renal damage associated with hypertension
6.Telmisartan & Metoprolol Succinate (ER) Tablets SEYTEL-M 50
Strength - 50 mg Pack
Size - 10 x 10 Tablets (Alu-Alu blister)
Telmisartan IP – 40 mg
Metoprolol Succinate IP – 47.5 mg
(Equivalent to Metoprolol Tartrate IP 50 mg)Release Type: Extended Release (ER)
Colour: Ferric Oxide Yellow USP-NF
Effectively controls high blood pressure
Provides dual action by relaxing blood vessels and reducing heart workload
Helps maintain stable blood pressure throughout the day (ER formulation)
Reduces the risk of heart attack, stroke, and cardiovascular complications
Improves heart efficiency and rhythm control
Suitable for patients requiring combination therapy for better BP control
Hypertension (High Blood Pressure)
Essential hypertension not adequately controlled by single therapy
Cardiovascular risk reduction in hypertensive patients
Heart rate control associated with hypertension
Prevention of complications such as stroke and heart disease
7.Rosuvastatin 10 mg & Clopidogrel 75 mg Capsules ROSSTAT CV 10
Strength - Rosuvastatin: 10 mg & Clopidogrel: 75 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 10 mgClopidogrel Bisulphate IP
Equivalent to Clopidogrel – 75 mgCapsule Type: Hard gelatin capsule
Colours: Approved colours for capsule shells
Effectively reduces LDL (bad) cholesterol and triglycerides
Helps prevent blood clot formation
Lowers the risk of heart attack and stroke
Provides dual cardiovascular protection (lipid-lowering + antiplatelet action)
Helps maintain healthy blood flow in arteries
Ideal for patients with high cardiovascular risk
Dyslipidaemia (high cholesterol levels)
Prevention of atherosclerotic cardiovascular disease
Patients with coronary artery disease (CAD)
Post-myocardial infarction (heart attack)
Post-angioplasty or stent placement
Prevention of thrombotic events such as stroke and heart attack
8.Metoprolol Succinate Extended-Release Tablets IP 25 mg Rx SEYMET-25
Strength - 25 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Metoprolol Succinate IP – 23.75 mg
(Equivalent to Metoprolol Tartrate IP 25 mg)Colour: Titanium Dioxide IP
Effectively lowers high blood pressure
Helps reduce heart rate and cardiac workload
Provides 24-hour blood pressure control due to extended-release action
Helps prevent angina (chest pain)
Reduces the risk of heart attack and cardiovascular complications
Improves heart rhythm stability
Hypertension (High Blood Pressure)
Angina pectoris
Heart rate control in cardiac conditions
Post-myocardial infarction (heart attack) management
Chronic stable heart failure (as advised by the physician)
9.Rosuvastatin 10 mg, Clopidogrel 75 mg & Aspirin 75 mg Capsules 10 x 10 Capsules ROSSTAT GOLD 10
Strength - Rosuvastatin: 10 mg , Clopidogrel: 75 mg & Aspirin: 75 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 10 mgClopidogrel Bisulphate IP
Equivalent to Clopidogrel – 75 mgAspirin IP – 75 mg
(as gastro-resistant enteric-coated pellets)Capsule Type: Hard gelatin capsule
Colours: Approved colours for capsule shells
Lowers LDL (bad) cholesterol and triglycerides
Prevents platelet aggregation and blood clot formation
Provides triple cardiovascular protection (statin + dual antiplatelet action)
Reduces the risk of heart attack, stroke, and other thrombotic events
Helps maintain healthy blood flow in coronary arteries
Improves long-term cardiovascular outcomes in high-risk patients
Coronary artery disease (CAD)
Post-myocardial infarction (heart attack)
Post-angioplasty or stent placement
Prevention of atherosclerotic cardiovascular disease
High cholesterol with associated cardiovascular risk
Secondary prevention of stroke and heart attack
10.Metoprolol Succinate Extended-Release Tablets IP 50 mg SEYMET-50
Strength - 50 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Metoprolol Succinate IP – 47.50 mg
(Equivalent to Metoprolol Tartrate IP 50 mg)Colours: Lake of Sunset Yellow FCF & Titanium Dioxide IP
Effectively controls high blood pressure
Reduces heart rate and cardiac workload
Provides 24-hour blood pressure control due to extended-release formulation
Helps prevent angina (chest pain)
Reduces the risk of heart attack and cardiovascular complications
Improves heart rhythm stability and overall cardiac function
Hypertension (High Blood Pressure)
Angina pectoris
Heart rate control in cardiovascular conditions
Post-myocardial infarction (heart attack) management
Chronic stable heart failure (as advised by the physician)
11.Rosuvastatin 20 mg & Clopidogrel 75 mg Capsules ROSSTAT CV 20
Strength - Rosuvastatin: 20 mg Clopidogrel: 75 mg Aspirin: 75 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 20 mg
(as light orange coloured film-coated tablet)Clopidogrel Bisulphate IP
Equivalent to Clopidogrel – 75 mg
(as two light brown coloured film-coated tablets, each containing Clopidogrel 37.5 mg)Aspirin IP – 75 mg
(as gastro-resistant enteric-coated pellets)Colours: Approved colours used in capsule shells
Effectively lowers LDL (bad) cholesterol and triglycerides
Prevents platelet aggregation and blood clot formation
Provides triple cardiovascular protection
(statin + dual antiplatelet therapy)Reduces the risk of heart attack and ischemic stroke
Helps maintain healthy blood flow in coronary arteries
Improves long-term cardiovascular outcomes in high-risk patients
Coronary artery disease (CAD)
Post-myocardial infarction (heart attack)
Post-angioplasty or stent placement
Prevention of atherosclerotic cardiovascular disease
Secondary prevention of stroke and heart attack
Patients with high cholesterol and high cardiovascular risk
12.Rosuvastatin 20 mg & Clopidogrel 75 mg Capsules ROSSTAT CV 20
Strength - Rosuvastatin: 20 mg Clopidogrel: 75 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 20 mg
(as light orange coloured film-coated tablet)Clopidogrel Bisulphate IP
Equivalent to Clopidogrel – 75 mg
(as two light brown coloured film-coated tablets, each containing Clopidogrel 37.5 mg)Colours: Sunset Yellow, Ferric Oxide Red USP-NF & Titanium Dioxide IP
Approved colours used in capsule shells
Lowers LDL (bad) cholesterol and total cholesterol
Prevents platelet aggregation and blood clot formation
Provides dual cardiovascular protection (statin + antiplatelet)
Reduces risk of heart attack and ischemic stroke
Improves blood flow in coronary and cerebral arteries
Supports long-term cardiovascular risk reduction
Coronary artery disease (CAD)
Hypercholesterolemia with cardiovascular risk
Post-myocardial infarction (heart attack)
Post-angioplasty or stent placement
Prevention of thrombotic and ischemic events
Atherosclerotic cardiovascular disease (ASCVD)
13.Rosuvastatin & Fenofibrate Tablets IP (10 mg + 160 mg) ROSSTAT F
Strength - Rosuvastatin: 10 mg Fenofibrate (Micronised): 160 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 10 mgFenofibrate (Micronised) IP – 160 mg
Excipients: q.s.
Colour: Titanium Dioxide IP
Effectively reduces LDL (bad cholesterol) and total cholesterol
Significantly lowers triglyceride levels
Helps increase HDL (good cholesterol)
Provides dual lipid-lowering action (statin + fibrate)
Reduces risk of atherosclerosis and cardiovascular complications
Improves overall lipid profile in mixed dyslipidaemia
Mixed dyslipidaemia
Hypercholesterolaemia with high triglycerides
Patients not adequately controlled on statin alone
Prevention of cardiovascular disease in high-risk patients
Diabetic dyslipidaemia
Atherosclerotic cardiovascular disease (ASCVD) risk reduction
14.Aspirin Gastro-Resistant and Rosuvastatin Capsules IP ROSSTAT ASP 10
Strength - Aspirin (Gastro-resistant): 75 mg Rosuvastatin: 10 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Aspirin IP – 75 mg
(as white coloured enteric-coated pellets)Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 10 mg
(as red coloured film-coated tablet)Colours: Ferric Oxide Red USP-NF & Titanium Dioxide IP
Approved colours used in the capsule shells
Helps prevent blood clot formation through antiplatelet action of aspirin
Effectively reduces LDL (bad cholesterol) and total cholesterol
Provides dual cardiovascular protection (antiplatelet + statin)
Reduces risk of heart attack and ischemic stroke
Improves coronary and cerebral blood flow
Suitable for long-term cardiovascular risk management
Coronary artery disease (CAD)
Post-myocardial infarction (heart attack)
Post-angioplasty or stent placement
Prevention of thrombotic and ischemic events
Patients with dyslipidaemia and high cardiovascular risk
Secondary prevention of stroke and heart attack
15.Aspirin Gastro-Resistant and Rosuvastatin Capsules IP ROSSTAT ASP 20
Strength - Aspirin (Gastro-resistant): 75 mg Rosuvastatin: 20 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Aspirin IP – 75 mg
(as white coloured enteric-coated pellets)Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 20 mg
(as red coloured film-coated tablet)Colours: Ferric Oxide Red USP-NF & Titanium Dioxide IP
Approved colours used in the capsule shells
Prevents platelet aggregation and blood clot formation
Effectively lowers LDL (bad cholesterol) and total cholesterol
Provides dual cardiovascular protection (antiplatelet + statin)
Reduces risk of heart attack and ischemic stroke
Improves coronary and cerebral blood circulation
Suitable for long-term cardiovascular risk management
Coronary artery disease (CAD)
Post-myocardial infarction (heart attack)
Post-angioplasty or stent placement
Secondary prevention of stroke
Patients with dyslipidaemia and high cardiovascular risk
Prevention of thrombotic cardiovascular events
16.Rosuvastatin Tablets IP 40 mg ROSSTAT 40
Strength - 40 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 40 mgExcipients – q.s.
Colours: Ferric Oxide Yellow USP-NF & Titanium Dioxide IP
Potently reduces LDL (bad cholesterol) and total cholesterol
Raises HDL (good cholesterol) levels
Lowers triglyceride levels
Helps slow progression of atherosclerosis
Significantly reduces risk of heart attack and stroke
Suitable for patients requiring high-intensity statin therapy
Primary hypercholesterolaemia
Mixed dyslipidaemia
Familial hypercholesterolaemia
Patients with high cardiovascular risk
Prevention of cardiovascular events (myocardial infarction, stroke)
Patients not adequately controlled with lower-dose statins
17.Rosuvastatin Tablets IP 10 mg ROSSTAT 10
Strength - 10 mg
Size - 10 x 10 Tablets (Alu-Alu blister)
Rosuvastatin Calcium IP
Equivalent to Rosuvastatin – 10 mgExcipients – q.s.
Colours: Sunset Yellow FCF & Titanium Dioxide IP
Effectively lowers LDL (bad cholesterol)
Helps increase HDL (good cholesterol)
Reduces triglyceride levels
Slows the progression of atherosclerosis
Helps prevent heart attack and stroke
Suitable for long-term cholesterol management
Well-tolerated starter dose statin therapy
Primary hypercholesterolaemia
Mixed dyslipidaemia
Early or moderate lipid abnormalities
Prevention of cardiovascular diseases
Patients with risk factors such as diabetes, hypertension, or smoking
Initial statin therapy before dose escalation